CA77.1 是一种新型伴侣介导的自噬激活剂，用于治疗阿尔茨海默病。它是 AR7 的衍生物，可以增加溶酶体受体在溶酶体中的表达。

CA77.1(CA) is a novel chaperon-mediated autophagy (CMA) activator for the treatment of Alzheimer's disease (AD).

2412270-22-3

C16H12ClN3O

297.74

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years